Alvotech to raise cash after third FDA rejection for Humira biosimilar

Alvotech and Teva won’t launch their copycat version of AbbVie’s inflammatory disease drug Humira as planned in July after the Food and Drug Administration once again cited manufacturing issues at a plant in Iceland.